In QuotedData’s morning briefing 16 May 2023: Apax Global Alpha (APAX) announced that it has signed a definitive agreement to acquire a significant minority stake in IBS Software through the Apax XI Fund in which APAX is a limited partner. IBS is a leading provider of modern software solutions to the global travel and logistics industry. […]
HydrogenOne announced its quarterly net asset value and portfolio update for the period ended 31 March 2023. The company NAV grew 2.8% over the quarter and is up 3.3% year on year. Despite the positive NAV returns, shares were down more than 40%, although they are up 24% since the beginning of May. Some of […]
Oakley Capital Investments Limited (OCI) announced that the Oakley Capital Fund III has reached an agreement to realise its stake in IU Group, the largest and fastest-growing university in Germany and a global leader in education technology. OCI’s share of proceeds, subject to completion, will be c.£240 million, with the sale agreed at the 31 […]
3i Infrastructure (3IN) announced its annual results for the year-end 31 March 2023. The company achieved a 14.7% NAV return for the year, delivery of the FY23 dividend target of 11.15 pence, and a 6.7% increase in the target dividend for FY24 to 11.90 pence per share. Despite the solid NAV performance, shares were down […]
GCP Infrastructure Investments Limited (GCP) announced the publication of its quarterly investment report. At 31 March 2023: The net asset value was, as previously announced, 112.24 pence per ordinary share, an increase of around 9% over the past year; The company was exposed to a diversified and partially inflation protected portfolio of 49 investments with […]
Downing Strategic Micro-Cap Investment Trust (DSM) announced the company’s results for the year ended 28 February 2023. The company saw a 8.7% decrease in NAV per share and 9.7% decrease in the share price, compared to a 17.4% decrease in the FTSE AIM All-Share TR index over the 12 months to 28 February 2023, driven […]
RTW Venture Fund Limited (RTW) provided an update for one of its portfolio companies, Acelyrin which announced an up-sized $540 million initial public offering and admission to trade on the Nasdaq Global Market under ticker “SLRN”. Acelyrin is a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology. […]
Chrysalis Investments announced a quarterly NAV update and a trading update for 31 March 2023. The unaudited net asset value per ordinary share was 130.02 pence. March’s NAV represents a 1.76 pence per share (1.4%) increase since 31 December 2022. Movements in fair values of the portfolio accounted for approximately 3.1 pence per share, with […]
Henderson International Income (HINT) announced results for the half-year ended 28 Feb 2023. During the six month period, the net asset value total return per ordinary share was 2.2% (debt at par) and 2.8% (debt at fair value). The company’s return on the ordinary share price was 6.5%. This included dividends totalling 3.7p per share […]
International Biotech (IBT) announced its half-yearly report for the year ended 28 Feb 2023. The company’s share price was up 8.0% over the six month period, well ahead of the Nasdaq Biotechnology Index (NBI), which had a total return of 1.8%. The company’s Net Asset Value total return over the period was 6.1%. Over three […]
